Soreness and ulcers 5, Biology, diagnosis and management of cancer regimen-related oral mucosal injury, part 1 of 2 /

Get full text
Series

Soreness and ulcers 5, biology, diagnosis and management of cancer regimen-related oral mucosal injury, part 2 of 2 /

Get full text
Series

Novel treatments for GI malignancies

Get full text
Series (Cancer therapies in the personalized medicine era)
Series (Gastroenterology and hepatology)

Overview of clinical pharmacology in cancer part 1 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 1 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 1 of 2 /

Get full text
Series

Overview of clinical pharmacology in cancer part 2 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 2 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 2 of 2 /

Get full text
Series

Immune checkpoint blockade in melanoma

Get full text
Series

Acute oral complications of cancer therapy

Get full text
Series

Case studies of adaptive early phase trials

Get full text
Series

Biomarkers and surrogate endpoints in randomized clinical trials

Get full text
Series

Adaptive designs for phase I trials part 1 of 2 /

Get full text
Series (Risk of bias in randomized clinical trials)
Series (Adaptive clinical trial design)

Chemotherapy-induced neuropathy incidence, natural history, measurement, prevention, and treatment /

Get full text

Cytochrome P450 1 family the roles of 1A1, 1A2 and 1B1 in drug metabolism /

Get full text
Series

Immune checkpoint blockade in renal cell carcinoma

Get full text
Series (Immunotherapy of cancer)
Series (Kidney in health and disease)

Immune checkpoint blockade in CNS tumors

Get full text
Series

Genomics of lung cancer

Get full text
Series

CLL novel prognostics, and updates on therapy - part 2 of 2 /

Get full text